ESMO Gastrointestinal Cancers Congress 2024: What To Exp
ESMO Gastrointestinal Cancers Congress 2024: Why You Sh
ESMO Gastrointestinal Cancers Congress 2024: Submit your
WHO-ESMO Collaboration Plan 2024-2026
ESMO Sarcoma and Rare Cancers 2024: What you can
ESMO Summit Latin America 2024: Invitation from the ESM
GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMat
ESMO Gynaecological Cancers Congress 2024 Members of t
ESMO Gastrointestinal Cancers Congress 2024: Reasons To
Advancements in metastatic ER+ breast cancer at ESMO
HER2+ and PIK3DA-mutated breast cancer updates from E
ESMO Immuno-Oncology 2024 Congress M. Maio, A. Marabe
ESMO 2023 GI Cancer Highlights – Codebreak300,
#ESMOGynae24 A dedicated event for the gynaecological
ESMO Sarcoma and Rare Cancers 2024: Robin L. Jone
Highlights in GI from ESMO 2023
Selected abstracts – Highlights of poster discussions and po
ESMO Sarcoma and Rare Cancers 2024: The Scientific
Highlights of Posters at ESMO GI on colorectal cancer
Key themes in colorectal cancer at ESMO WCGIC 2023
ESMO: GCIG INTERLACE STUDY
Predicting OS with PFS in pancreatic cancer in the NAP
ESMO Asia Congress 2024: multidisciplinary oncology i
ESMO Gynaecological Cancers Congress 2024: Share your r
#ELCC24: Global experts on why you should submit your
The emerging role of checkpoint inhibitors in liver
What novel non-G12C KRAS inhibitors are available in GI
Final analysis of KEYNOTE-585: pembrolizumab and che
Development of Foxy5, a WNT5A mimicking peptide, i
Unmet needs in screening for early onset colorectal cancer
